CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 197 enrolled
Drug / intervention
Med-eMonitor +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00406718
NCT00406718N/ACompleted
CompareCT.gov

Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia

The University of Texas Health Science Center at San Antonio·interventional·Posted Dec 4, 2006·Updated Oct 5, 2015

In Brief

A clinical study evaluating Med-eMonitor, PharmCAT, and 1 other intervention for Schizophrenia and Schizoaffective Disorder. Completed, enrolled 197 participants across 1 site.

Detailed Summary

This study will determine the comparative effectiveness of two systems designed to improve medication adherence in people with schizophrenia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Schizoaffective Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 4, 2006
Enrollment StartNov 1, 2006
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 19.6 years ago

Interventions

Med-eMonitorbehavioral

Participants will use the Med-eMonitor™ device, which is an electronic device that holds up to one month's supply of up to five medications. It is capable of cueing the taking of medication, warning patients when they are taking the wrong medication or taking it at the wrong time, recording side effect complaints, and through modem hookup promptly alerting treatment staff of failures to take medication as prescribed.

PharmCATbehavioral

Pharm CAT is a psychosocial intervention using environmental supports such as signs, alarms, checklists, and special medication containers to cue and sequence adaptive behavior in the patient's home environment. This treatment specifically targets adherence to medication, medication education, and orientation for patients with schizophrenia. Participants will receive weekly home visits from a case manager.

Treatment as Usualbehavioral

Participants receiving standard treatment will keep the Med-eMonitor™ device in their homes throughout the study but will not use its medication reminder function.